HEALTHCARE INNOVATIONS VENTURE FUND, LLC

Profile

Company Names

HEALTHCARE INNOVATIONS VENTURE FUND, LLC

Addresses

280 S MANGUM STREET, SUITE 350, DURHAM, NC 27701

Phone Numbers

919-484-0730

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

VENTURE CAPITAL FUND

Year Incorporated:

> 5 years ago

State Incorporated:

NORTH CAROLINA

Total Amount Raised:

$25,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-10-06 
$25,000,000.00 
$125,000,000.00 
$100,000,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
C. 
CRUMPLER 
EXECUTIVE OFFICER
HATTERAS VENTURE PARTNERS IV, LP   |  HATTERAS VENTURE PARTNERS V, LP   |  MEDFUSION, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC   |  HEALTHCARE INNOVATIONS VENTURE FUND, LLC
- 
 
HATTERAS VENTURE ADVISORS VI, LLC 
EXECUTIVE OFFICER, DIRECTOR
HATTERAS VENTURE PARTNERS VI, LP   |  HATTERAS CREATE SF SPV, LLC   |  HEALTHCARE INNOVATIONS VENTURE FUND, LLC
DOUGLAS 
 
REED 
EXECUTIVE OFFICER
SPINEWORKS MEDICAL INC   |  SPINEALIGN MEDICAL INC   |  VIAMET PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  HATTERAS VENTURE PARTNERS IV, LP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  NEUROTRONIK, INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  COFERON, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  BLINKBIO, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  QPEX BIOPHARMA, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  EMX ROYALTY CORP   |  AVIVOMED INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC   |  HEALTHCARE INNOVATIONS VENTURE FUND, LLC
CHRISTY 
 
SHAFFER 
EXECUTIVE OFFICER
CLINIPACE INC   |  EVOAPP, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.   |  KINODYN, INC.   |  SPYRYX BIOSCIENCES, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  GRAYBUG, INC.   |  TREFOIL THERAPEUTICS, INC.   |  GRAYBUG VISION, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  PERFUSE THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  AER THERAPEUTICS, INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC   |  HEALTHCARE INNOVATIONS VENTURE FUND, LLC
CLAY 
B. 
THORP 
EXECUTIVE OFFICER
ARTUSLABS INC   |  HATTERAS VENTURE PARTNERS IV, LP   |  HATTERAS VENTURE PARTNERS V, LP   |  CLEARSIDE BIOMEDICAL, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC   |  HEALTHCARE INNOVATIONS VENTURE FUND, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-20
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#